Liver Innovation Shows Potential to Avoid Transplants
Adrianna bought awareness to her platform, End Stage Renal Disease (ESRD) through her involvement in a University of California, San Francisco project focused on the creation of a free standing, surgically implanted bioartificial
kidney designed to treat ESRD.
PharmaCyte plans to encapsulate Melligen cells using the Cell-in-a-Box technology to protect the Melligen cells from immune system attack in the body and thus function as a "bioartificial
pancreas" for purposes of insulin production.
The Kidney Project: Creating a bioartificial
kidney as a permanent solution to end stage renal disease.
Defymed has developed MailPan, a bioartificial
pancreas device designed, using suitable cells such as Kadimastem's cells, to treat diabetes in patients without the use of immunosuppressants.
The impact of extracellular matrix coatings on the performance of human renal cells applied in bioartificial
Ott et al., Perfusion-Decellularized Matrix: Using Nature's Platform to Engineer a Bioartificial
Heart, 14 NAT.
Also known as 'human heart-in-a-jar', Novoheart's bioartificial
human heart constructs are created using state-of-the-art stem cell and bioengineering approaches, and are utilized by drug developers for accurate preclinical testing as to the effectiveness and safety of new drugs, maximizing the successes in drug discovery whilst minimizing costs and harm caused to patients.
Combination of extrinsic and intrinsic pathways significantly accelerates axial vascularization of bioartificial
In this case, the islets are usually stored in a bioartificial
pancreas device and the de novo generated oxygen is produced by electrochemistry /photosynthesis  or exogenous oxygen and is delivered into the device for islet use.